Efficacy and feasibility of pharmacoscopy-guided treatment for acute myeloid leukemia patients who have exhausted all registered therapeutic options
Haematologica
.
2024 Feb 1;109(2):617-621.
doi: 10.3324/haematol.2023.283224.
Authors
Jonas Andreas Schmid
1
,
Yasmin Festl
2
,
Yannik Severin
2
,
Ulrike Bacher
3
,
Marie-Noëlle Kronig
4
,
Berend Snijder
5
,
Thomas Pabst
4
Affiliations
1
Faculty of Medicine University of Bern, Bern.
2
Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich.
3
Department of Hematology; Inselspital, University Hospital Bern, University of Bern, Bern.
4
Department of Medical Oncology; Inselspital, University Hospital Bern, University of Bern, Bern.
5
Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich. snijder@imsb.biol.ethz.ch.
PMID:
37439341
PMCID:
PMC10828754
DOI:
10.3324/haematol.2023.283224
No abstract available
MeSH terms
Feasibility Studies
Humans
Leukemia, Myeloid, Acute* / drug therapy